Tom Brassington
Partner Corporate & Finance
Languages
English
-
Overview
-
Experience
-
Credentials
-
Insights and events
Chambers UK'commercial in his attitude, view and outlook.'
Tom Brassington is a senior partner in the firm's London Corporate & Finance practice group.
He is ranked in Chambers Global for Corporate/M&A, with his expertise in international and cross-border M&A highlighted in particular.
He has experience across a wide variety of work including public and private M&A, joint ventures, restructurings, private equity, and equity capital markets. While Tom is a generalist M&A practitioner, he regularly acts for clients in the Life Sciences and Technology, Media & Telecoms sectors.
While Tom is based in London, he has also practiced in both Dubai and Hong Kong.
Chambers UKHe is a really perfect person to represent buyers who aren't based in the UK, because he has a good sense of the UK market and how US acquisitions are done, and does a good job of blending the two together.'
Representative experience
Advising Revvity, Inc. on the sale of its applied, food and enterprise services businesses to New Mountain Capital
Advising PerkinElmer, Inc. on public takeover offers for each Horizon Discovery Group plc, Oxford Immunotec Global plc and Immunodiagnostic Systems Holdings plc
Advising Novartis Institutes for Biomedical Research (NIBR) on its acquisition of Arctos Medical
Advising Sandoz AG on the acquisition of the worldwide product rights for Mycamine®, an antifungal agent, from Astellas Pharma Inc
Advising Smiths Group plc on the acquisitions of Seebach GmbH and United Flexible, Inc and its investment in Ivenix, Inc
Advising Google on a variety of corporate transactions in the UK
Advising The British Council on the sale of its IELTS business in India to IDP Education Limited
Advising The Anschutz Corporation in respect of the US$5.8bn acquisition of Regal Entertainment Group by Cineworld Group plc
Advising Recordati on its US$300m acquisition of the European commercial rights to AstraZeneca's blood pressure and heart failure products, Seloken, Seloken ZOK and Logimax
Advising McCormick & Co. on its takeover offer for Premier Foods plc
Advising News Corporation on various transactions including the acquisitions of Shine and Unruly
Advising Electra Private Equity PLC on the demerger of Hostmore plc onto the London Stock Exchange
Advising Lockheed Martin on various transactions, including the separation and combination of its IT and technical services businesses with Leidos
Advising Intrexon Corporation on the acquisition of Oxitec Ltd., a pioneer in biological insect control solutions
Advising Jazz Pharmaceuticals PLC on the sale of a portfolio of pharmaceutical products and medical devices to Essex Woodlands Fund IX L.P
Advising Kingfisher PLC on the sale of its controlling stake in B&Q China to Beijing-based Wumei Holdings
Advising Johnson and Johnson on transactions including acquisitions of Spectrum Vision; OTC brands of JB Chemicals & Pharmaceuticals Limited; and Finsbury Orthopaedics on business disposal
Advising Bestway Group on the acquisition of the Co-operative Group's Pharmacy business for £620m
Advising Aeroflex on its US$1.5bn sale to Cobham plc
Advising the trustees of the Kodak Pension Plan on the acquisition of the Personalized Imaging and Document Imaging businesses of Eastman Kodak
Advising Ares Capital on its participation in a debt-for-equity swap and placing, and then subsequent take private, of Healthcare Locums plc
Advising RBC Capital Markets as sponsor to Petra Diamonds Limited's admission to the Official List and to trading on the Main Market of the LSE
Advising Moor Park on the £700m sale and leaseback of 12 Spire Healthcare hospitals
Advising Numis Securities Limited in its capacity as nominated adviser and broker to Clinigen Group Plc on Clinigen's IPO and admission to AIM
Credentials
- The University of Nottingham
- Member, City of London Solicitors' Company Law Committee
- Law Society